Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.
about
Genetic heterogeneity in Alzheimer disease and implications for treatment strategiesNeuropathological and biochemical assessments of an Alzheimer's disease patient treated with the γ-secretase inhibitor semagacestat.Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging.PERK activation mitigates tau pathology in vitro and in vivo.Widespread white matter and conduction defects in PSEN1-related spastic paraparesis.
P2860
Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Subjects harboring presenilin ...... tter biochemistry alterations.
@en
Subjects harboring presenilin ...... tter biochemistry alterations.
@nl
type
label
Subjects harboring presenilin ...... tter biochemistry alterations.
@en
Subjects harboring presenilin ...... tter biochemistry alterations.
@nl
prefLabel
Subjects harboring presenilin ...... tter biochemistry alterations.
@en
Subjects harboring presenilin ...... tter biochemistry alterations.
@nl
P2093
P2860
P1476
Subjects harboring presenilin ...... tter biochemistry alterations.
@en
P2093
Alex E Roher
Bernardino Ghetti
Charisse M Whiteside
Chera L Maarouf
Ian D Daugs
Jeffrey Wilson
Marwan N Sabbagh
Mimi P Macias
Sandra A Jacobson
Tyler A Kokjohn
P2860
P304
P577
2013-09-18T00:00:00Z